Anticancer Potency of Methanol Extract from Terminalia catappa Leaves Using In Vitro and In Silico Methods
DOI:
https://doi.org/10.48048/tis.2024.8057Keywords:
Antiproliferative, Bcl-2, DU145 cell, HeLa cell, In silico, LC-MS/MS, T. catappaAbstract
Terminalia catappa is a plant with potential for application in various antioxidant, anti-inflammatory, antimetastatic and antitumor treatments. Therefore, this study aimed to investigate anticancer properties of methanol extract derived from T. catappa leaves, using both in vitro and in silico methods. The results showed that methanol extract had inhibition of HeLa and DU145 cell lines, with respective IC50 values of 352.50 and 954.99 μg/mL. LC-MS/MS analysis identified several active compounds within the extract, including catechin, quercetin, rutin, hirsutrin, loliolide, sesquiterpene, kaempferol, apigenin, cirsiliol, cirsimaritin and demethoxycurcumin, all of which had promising anticancer potential. These compounds performed well in the in silico test. According to computational predictions, rutin (−9.1 kcal/mol), catechin (−8.0 kcal/mol) and sesquiterpene (−8.2 kcal/mol) had higher binding affinity values than cisplatin and paclitaxel (−7.5 kcal/mol). Considering these results, the compounds were potentially anticancer agents through the inhibition of the Bcl-2 protein. Finally, T. catappa active compounds can be used as alternative candidates as a chemopreventive agent.
HIGHLIGHTS
- Methanol extract from Terminalia catappa leaves could inhibit the proliferation of HeLa and DU145 cell lines.
- Methanol extract of Terminalia catappa leaves showed antiproliferative activity with IC50 of 352.50 μg/mL in HeLa and 954.99 μg/mL in DU145 cells.
- Rutin, a component of the methanol extract of Terminalia catappa leaves, showed a high affinity binding to Bcl-2 in silico.
- The extract could be beneficial to develop as a chemopreventive agent.
GRAPHICAL ABSTRACT
Downloads
References
KA Ghani, S Sudik, AF Omar, MH Mail and A Seeni. VIS-NIR spectral signature and quantitative analysis of HeLa and DU145 cell line. Spectrochim. Acta A Mol. Biomol. Spectros. 2019; 222, 117241.
F Bray, J Ferlay, I Soerjomataram, RL Siegel, LA Torre and A Jemal. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Canc. J. Clin. 2018; 68, 394-424.
World Health Organization. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. International Agency for Research on Cancer, Geneva, Switzerland, 2018.
B Yang, Y Cai, P Zhu, Z Jiang, J Ao, Q Zhang, W Yuan, Z Peng, J Chen, Y Wen, Y Chen, Y Wang, Y Shi, X Zhu, X Ye, F Li, J Zhuang, X Wu, Y Li and X Fan. Transmembrane protein 121 as a novel inhibitor of cervical cancer metastasis. Exp. Ther. Med. 2022; 24, 572.
P Rawla. Epidemiology of prostate cancer. World J. Oncol. 2019; 10, 63-89.
IG Alghamidi, II Hussain, MS Alghamdi and MA El-Sheemy. The incidence rate of prostate cancer in Saudi Arabia: An observational descriptive epidemiological analysis of data from the Saudi cancer registry 2001 - 2008. Hematol. Oncol. Stem Cell Ther. 2014; 7, 18-26.
MF Abd Ghani, R Othman and N Nordin. Molecular docking study of naturally derived flavonoids with antiapoptotic BCL-2 and BCL-XL proteins toward ovarian cancer treatment. J. Pharm. BioAllied Sci. 2020; 12, S676-S680.
A Yilmaz, E Alp, H Onen and S Menevse. Reduced BCL-2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel. Contemp. Oncol. 2016; 20, 28-32.
A Ali and G Kulik. Signaling pathways that control apoptosis in prostate cancer. Cancers 2021; 13, 937.
Y Wei, X Pu and L Zhao. Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy (Review). Oncol. Rep. 2017; 37, 3159-66.
H Zhu, H Luo, W Zhang, Z Shen, X Hu and X Zhu. Molecular mechanisms of cisplatin resistance in cervical cancer. Drug Des. Dev. Ther. 2016; 10, 1885-95.
S Hager, CJ Ackermann, M Joerger, S Gillessen and A Omlin. Anti-tumour activity of platinum compounds in advanced prostate cancer - a systematic literature review. Ann. Oncol. 2016; 27, 975-84.
MM Munira, RR Rasidah, EM Melani, NZ Zakiah and MN Nasir Antibacterial activity test of ethanol extract of ketapang leaves (Terminalia catappa L.) green and red colors and their combinations (in Indonesian). Indonesian J. Pharm. Nat. Prod. 2018; 1, 8-13.
H Zarredar, AM Khamaneh, FF Amoodizaj, D Shanehbandi, E Seyedrezazadeh, HS Jadid, M Asadi, V Zafari, Y Khalili, Z Soleimani, A Ansarin and M Khalili. Terminalia catappa Extract (TCE) reduces proliferation of lung and breast cancer cell by modulating miR-21 and miR-34a expressions. Asian Pac. J. Canc. Prev. 2021; 22, 1157.
MJ Kaneria, KD Rakholiya, LR Marsonia, RA Dave and BA Golakiya. Nontargeted metabolomics approach to determine metabolites profile and antioxidant study of tropical almond (Terminalia catappa L.) fruit peels using GC-QTOF-MS and LC-QTOF-MS. J. Pharmaceut. Biomed. 2018; 160, 415-27.
D Shanehbandi, H Zarredar, M Asadi, V Zafari, S Esmaeili, E Seyedrezazadeh, Z Soleimani, HS Jadid, S Eyvazi, S Feyziniya, SB Moghadam and M Khalili. Anticancer impacts of Terminalia catappa extract on SW480 colorectal neoplasm cell line. J. Gastrointest. Canc. 2021; 52, 99-105.
CB Yeh, MJ Hsieh, YS Hsieh, MH Chien, PY Lin, HL Chiou and SF Yang. Corrigendum to Terminalia catappa exerts antimetastatic effects on hepatocellular carcinoma through transcriptional inhibition of matrix metalloproteinase-9 by modulating NF-B and AP-1 activity. Evid. Base. Compl. Alternative Med. 2015; 2015, 326234.
N Bennour, H Mighri, H Eljani, T Zammouri and A Akrout. Effect of solvent evaporation method on phenolic compounds and the antioxidant activity of Moringa oleifera cultivated in Southern Tunisia. S. Afr. J. Bot. 2020; 129, 181-90.
C Claudioa, S Juan, S Yesenniab, P Nayelyc, M Irened, P Esthere, N Sergio, S Rosa, N María, H Renea, C Shankararamanf and G Claudia. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells. Anti Canc. Drugs 2020; 31, 251-9.
G Izdihar, AA Naini, D Harneti, R Maharani, N Nurlelasari, T Mayanti, A Safari, K Farabi, U Supratman, MN Azmi and Y Shiono. Sesquiterpenoids from the stem bark of Aglaia simplicifolia and their cytotoxic activity against B16-F10 melanoma skin cancer cell. Indonesian J. Chem. 2021; 21, 1560-7.
D Widiastuti, SE Sinaga, S Warnasih, E Pujiyawati, S Salam and WE Putra. Identification of active compounds from Averrhoa bilimbi L. (Belimbing Wuluh) flower using LC-MS and antidiabetic activity test using in vitro and in silico approaches. Trends Sci. 2023; 20, 6761.
JS Chaleshtori, E Heidari-Sureshjani, F Moradi and E Heidarian. The effects of Thymoquinone on viability, and anti-apoptotic factors (BCL-XL, BCL-2, MCL-1) in prostate cancer (PC3) cells: An in vitro and computer-simulated environment study. Adv. Pharmaceut. Bull. 2019; 9, 490-6.
MS Majoumouo, MB Tincho, RMK Toghueo, T Morris, DC Hiss, FF Boyom and C Mandal. Cytotoxicity potential of endophytic fungi extract from Terminalia catappa against human cervical cancer cells. J. Toxicol. 2020; 2020, 8871152.
C Rodríguez-García, C Sánchez-Quesada and JJ Gaforio. Dietary flavonoids as cancer chemopreventive agents: An updated review of human studies. Antioxidants 2019; 8, 137.
DM Kopustinskiene, V Jakstas, A Savickas and J Bernatoniene. Flavonoids as anticancer agents. Nutrients 2020; 12, 457.
DDA Bakhtra, HSK Uyun, A Eriadi, A Fajrina, S Wiliantari, W Pranciska and JD Wandani. Effect of catechin administration on cervical cancer cell culture (in Indonesian). Jurnal Farmasi Higea 2023; 15, 163-70.
A Fadlan, T Warsito and Sarmoko. In silico approach in uncovering the anticancer potential of Meciadanol (in Indonesian). J. Kim. Ris. 2021; 6, 163-71.
M ben Sghaier, A Pagano, M Mousslim, Y Ammari, H Kovacic and J Luis. Rutin inhibits proliferation, attenuates superoxide production, and decreases adhesion and migration of human cancerous cells. Biomed. Pharmacother. 2016; 84, 1972-8.
AJ Robles, J Peng, RM Hartley, B Lee and SL Mooberry. Melampodium leucanthum a source of cytotoxic sesquiterpenes with antimitotic activities. J. Nat. Prod. 2015; 78, 388-95.
S Warnasih, AH Mulyati and S Kholisoh. Molecular docking studies of Phoenix dactylifera L. against SARS-CoV-2 ACE-2 receptor. Jurnal Kartika Kimia 2022; 5, 107-17.
CL Chen, SC Hsu, DK Ann, Y Yen and HJ Kung. Arginine signaling and cancer metabolism. Cancers 2021; 13, 3541.
A Yuniastuti, AN Khasanah, NW Harini, W Christijanti and DH Utomo. Apoptosis potency prediction of steroid saponin from Gembili (Dioscorea esculenta) as Bcl-2 and Bcl-xL inhibitors in Colon cancer. Trends Sci. 2022; 13, 3541.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
